Trend study on the future of the healthcare market
The age structure of our society is leading to an increasing demand for medical services, while limited resources and the trend towards part-time work are making the situation more difficult. The growing need for care, a shortage of specialists and limited financial resources are among the biggest challenges. At the same time, healthcare is becoming increasingly personalized, technological and holistic. Initial results of the study show that the "4 Ps" - personalization, prevention, mental health and public health - will shape the healthcare world of tomorrow. These trends will be important in both urban and rural areas and will contribute to greater patient focus and an improved quality of life.
The future belongs to innovative providers and start-ups
The study highlights the trends and developments and emphasizes the role of start-ups as trailblazers and pioneers of change. Health start-ups made in Germany are developing more precise, efficient and people-centered solutions and addressing social challenges such as loneliness, depression and dementia.
Exclusively for Ecclesia customers: Early access to the study results
Secure your access to the complete trend study "Health Startups made in Germany" now. As a client of the Ecclesia Group, you have the opportunity to view the results of the entire study even before the official publication. Simply register using our online form and you will find out first-hand how innovative start-ups are changing the market and which solutions you can adopt for your own organization.
Germany is in a better position than many think
There are around 1,300 healthcare start-ups in Germany that are in a dynamic growth phase. Berlin leads the way, accounting for around a third of all start-ups in the healthcare sector, followed by Munich and Hamburg. Digital healthcare services, medtech, biotechnology and pharma are the main drivers of these innovations. While major cities are acting as innovation centers, smaller regions are also catching up in terms of founding new, innovative companies.
Christian Kannemeier, Senior Investment Manager in the Life Science Team at HTGF, a venture capital investor for innovative technologies and business models, confirms this in an interview with Dr. Daniel Dettling, Managing Director of Gesundheitsstadt Berlin and co-initiator of the trend study: "Germany is in a better position internationally than many people think." Thanks to numerous public subsidies and extensive expertise, Germany is strongly positioned, particularly in drug development, oncology and neurodegeneration. "Cell therapies are a large market that is continuing to develop and where a lot is yet to happen," adds Christian Kannemeier. The initiative for cell and gene therapy plays a central role in this and will establish Germany as an attractive market in the long term.
Innovative insurance solutions
"We cover the new risks arising from the changes in the healthcare market," emphasizes Markus Schäfer, Member of the Management Board of Ecclesia Versicherungsdienst GmbH. The current trend study is one of many ways of ensuring that the Ecclesia Group always keeps its finger on the pulse and promotes innovation. "By integrating the findings into our risk analysis at an early stage and actively participating in the development of new insurance products and conditions in close cooperation with insurers, we can offer our customers products that are precisely tailored to the needs and requirements of the industry," explains Schäfer.
So much for the first insights into the future of the healthcare market. More details and comprehensive results will follow soon.